The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) concluded in 2024 that no causal link has been established between GLP-1 receptor agonists and suicidal ideation or self-injury
We looked at the way that the state was supporting coverage for GLP-1 medicines and found that this was a fairly significant cost driver, Gov
A 2021 study found lecithin-based surfactants were less harsh and more tolerable comared to Sodium Lauryl Sulfate (SLS)
A provider may also consider whether inflammation, injury history, immune status, medication use, or underlying conditions require a different starting point
Its literally physically painful, and the emotional damage it can inflict upon you cant be overstated, either
Without nutritional guidance, up to 39% of weight lost on GLP-1s may come from lean muscle mass , which can lower metabolic rate and make long-term maintenance more difficult, a risk often overlooked in benefits planning